| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |